Prestige Consumer Healthcare Reaffirms FY24 Revenue Outlook Of $1.135B-$1.14B Vs. Consensus Of $1.03B, With EPS Of $4.27-$4.32 Vs. Consensus Of $3.92
Portfolio Pulse from Benzinga Newsdesk
Prestige Consumer Healthcare has reaffirmed its FY24 revenue outlook of $1.135B-$1.14B, which is higher than the consensus of $1.03B. The company also expects EPS of $4.27-$4.32, surpassing the consensus of $3.92.
August 04, 2023 | 12:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Prestige Consumer Healthcare's reaffirmed FY24 revenue and EPS outlooks are higher than the consensus, which could positively impact the company's stock.
Prestige Consumer Healthcare's reaffirmed FY24 revenue outlook of $1.135B-$1.14B is higher than the consensus of $1.03B, and its EPS outlook of $4.27-$4.32 is also above the consensus of $3.92. This could lead to increased investor confidence and a potential rise in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100